MAM
ICPT

Monaco Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Monaco Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,000
Closed -$414K – 86
2022
Q2 		$414K Buy
+30,000
New +$480K 0.18% 58

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Monaco Asset Management's ICPT Position: Q3 2022 in Review

Monaco Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2022, closing a stake of 30,000 shares — an estimated $414K sold.

Monaco Asset Management first reported a position in ICPT in Q2 2022 and held it in 1 quarter. The position peaked at $414K in Q2 2022. 156 funds tracked by Wall St. Rank hold ICPT as of Q3 2022.

  • Monaco Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • Monaco Asset Management sold 30,000 Intercept Pharmaceuticals, Inc. shares in Q3 2022, an estimated $414K.
  • Monaco Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2022 and held it in 1 quarter.
  • Monaco Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $414K in Q2 2022.
  • 156 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2022.

Based on Monaco Asset Management's 13F filing for Q3 2022, filed 31 Oct 2022.